Angiotensin II and Aldosterone stimulating NF-κB and AP-1 activation in hepatic fibrosis of rat

Regulatory Peptides

Volumn 138, Issue 1, 2007, Pages 15-25

  Li, Xu ^a   Meng, Ying ^a   Wu, Pingsheng ^a   Zhang, Zhenshu ^a   Yang, Xishan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Active protein 1; Aldosterone; Angiotensin II; Liver cirrhosis; NF B; Renin angiotensin aldosterone system

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ACETYLCYSTEINE; ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; CARBON TETRACHLORIDE; GAG PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRBESARTAN; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PERINDOPRIL; PHOSPHOPROTEIN; PROCOLLAGEN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROGENESIS; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE TARGETING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER FIBROSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STELLATE CELL; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; NF-KAPPA B; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTOR AGENTS;

EID: 33845476271     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.07.011     Document Type: Article

References (27)

1. Friedman S.L. The cellular basis of hepatic fibrosis. N Engl J Med 328 (1993) 1828-1835
2. Paizis G., Cooper M.E., Schembri J.M., et al. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123 (2002) 1667-1676
3. Powell E.E., Edwards-Smith C.J., Hay J.L., et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31 (2000) 828-833
4. Ramalho L.N., Ramalho F.S., Zucoloto S., et al. Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis. Hepato-gastroenterol 49 (2002) 1499-1502
5. Croquet V., Moal F., Veal N., et al. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension. J Hepatol 37 (2002) 773-780
6. Paizis G., Gilbert R.E., Cooper M.E., et al. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 35 3 (2001) 376-385
7. Jonsson J.R., Clouston A.D., Ando Y., et al. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 121 (2001) 148-155
8. Yoshiji H., Yoshii J., Ikenaka Y., et al. Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. J Hepatol 37 (2002) 22-30
9. 4-induced liver fibrosis in rats. J UOEH 26 2 (2004) 165-177
10. Yoshiji H., Kuriyama S., Noguchi R., et al. Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development. Liver Int 25 1 (2005) 153-161
11. Yokohama S., Yoneda M., Haneda M., et al. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 40 5 (2004) 1222-1225
12. Caligiuri A., De Franco R.M., Romanelli R.G., et al. Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. Gastroenterology 124 (2003) 504-520
13. Yang X., Li X., Wu P., et al. CYP11B2 expression in rat liver and the effect of spironolactone on hepatic fibrogenesis. Horm. Res. 53 6 (2000) 288-293
14. Bataller R., Schwabe R.F., Choi Y.H., et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112 (2003) 1383-1394
15. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13 (1991) 372-374
16. Schwabe R.F., Bennett B.L., Manning A.M., et al. Differential role of I kappa B kinase 1 and 2 in primary rat hepatocytes. Hepatology 33 (2001) 81-90
17. Hellerbrand C., Jobin C., Licato L.L., et al. Cytokines induce NF-K{green}B in activated but not in quiescent rat hepatic stellate cells. Am J Physiol 275 (1998) G269-G278
18. Elsharkawy A.M., Wright M.C., Hay R.T., et al. Persistent activation of nuclear factor-kappa B in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IκB family proteins. Hepatology 30 (1999) 761-769
19. Barnes P.J., and Karim M. Nuclear factor-KB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 (1997) 1066-1071
20. Eickelberg O., Pansky A., Mussmann R., et al. Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem 274 (1999) 12933-12938
21. Chen A., and Davis B.H. The DNA binding protein BTEB mediates acetaldehyde-induced, Jun N-terminal kinase-dependent αI(I) collagen gene expression in rat hepatic stellate cells. Mol Cell Biol 20 (2000) 2818-2826
22. Baldwin A.S. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14 (1996) 649-681
23. Ghosh S., May M.J., and Kopp E.B. NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu Rev Immunol 16 (1998) 225-260
24. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18 (2000) 621-663
25. Vogt P.K. Jun, the oncoprotein. Oncogene 20 (2001) 2365-2377
26. Karin M., Liu Z., and Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 9 (1997) 240-246
27. Chinenov Y., and Kerppola T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20 (2001) 2438-2452